文献速递冠心病外科心外重症与机械循环支持

缺血性心肌病血运重建术中的机械循环支持

Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy.
PubMed 文献 · Ann Thorac Surg · 2024-01-30

研究纳入2015至2021年378例射血分数<35%行孤立冠状动脉旁路移植术的缺血性心肌病患者,按机械循环支持时机分为无、术前和术后三组。术前机械循环支持组手术死亡率7.7%与无支持组2.9%无显著差异(P=.12),术后机械循环支持组手术死亡率和晚期死亡率显著升高。作者认为选择性使用围术期机械循环支持可使手术安全进行。

要点

  • 射血分数<35%行孤立冠状动脉旁路移植术患者中,5.6%术前存在心源性休克。
  • 术前机械循环支持组与无支持组手术死亡率7.7%对2.9%(P=.12),长期生存无差异(P=.80)。
  • 术后机械循环支持组手术死亡率16.7%,晚期死亡率63%,均显著升高(P<.01)。

核心结论

  • 作者认为,缺血性心肌病患者可安全行冠状动脉旁路移植术,并选择性使用围术期机械循环支持。
  • 需术前机械循环支持的患者尽管病情严重,短期和长期生存仍可接受。
  • 需术后机械循环支持的患者术后并发症发生率和死亡率升高。

研究设计与样本

  • 回顾性队列研究,纳入2015至2021年射血分数<35%行孤立冠状动脉旁路移植术的378例缺血性心肌病患者。
  • 按机械循环支持时机分为无机械循环支持组、术前机械循环支持组和术后机械循环支持组,机械循环支持包括主动脉内球囊反搏、体外膜肺氧合或Impella装置(Abiomed)。
  • 主要结局为手术死亡率。

主要发现

  • 胸外科医师学会预测死亡风险中位数为2.4%。
  • 66%(n=246)患者有既往心肌梗死,其中61.8%在冠状动脉旁路移植术21天内。
  • 21例(5.6%)患者术前存在心源性休克。
  • 术前机械循环支持组31例(8.2%),在机械循环支持启动后中位2天行冠状动脉旁路移植术;术后机械循环支持组30例(7.9%)。
  • 需术后机械循环支持的独立危险因素包括术前射血分数(比值比0.93;P=.01)和术前存在机械循环支持(比值比3.06;P=.02)。

关键数值与推荐

  • 术前机械循环支持组与无术前机械循环支持组手术死亡率分别为7.7%和2.9%(P=.12),长期生存无差异(P=.80)。
  • 术后机械循环支持组手术死亡率为16.7%,晚期死亡率为63%(P<.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy who were undergoing surgical revascularization. METHODS: Patients with an ejection fraction <35% who underwent isolated coronary artery bypass grafting (CABG) from 2015 to 2021 were identified (N = 378). Patients were divided into no MCS, preoperative MCS, and postoperative MCS groups on the basis of timing of MCS initiation, which included intraaortic balloon pump, extracorporeal membrane oxygenation, or Impella device (Abiomed) use. The primary outcome of interest was operative mortality. RESULTS: The median Society of Thoracic Surgeons Predicted Risk of Mortality was 2.4%. Sixty-six percent (n = 246) of patients had a previous myocardial infarction, and 61.8% of these patients were within 21 days of CABG. Twenty-one patients (5.6%) presented in cardiogenic shock. The preoperative MCS cohort consisted of 31 patients (8.2%) who underwent CABG a median of 2 days after MCS initiation. Thirty (7.9%) patients required postoperative MCS. Independent risk factors for requiring postoperative MCS included the preoperative ejection fraction (odds ratio, 0.93; P = .01 and the presence of preoperative MCS (odds ratio, 3.06; P = .02). Overall, operative mortality was 3.4%, and 3-year survival was 87.0%. Operative mortality in patients who did and did not receive preoperative MCS was 7.7% and 2.9% (P = .12) with no difference in long-term survival (P = .80), whereas patients requiring postoperative MCS had significantly increased operative (16.7%) and late mortality (63%; P <.01). CONCLUSIONS: CABG can be performed safely in patients with ischemic cardiomyopathy with selective use of perioperative MCS. Despite advanced disease severity, patients requiring preoperative MCS demonstrate acceptable short- and long-term survival. Patients requiring postoperative MCS have increased postoperative morbidity and mortality.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Singh SK, Vinogradsky A, Kirschner M, et al. Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy. Ann Thorac Surg. 2024. PMID: 38302051. doi:10.1016/j.athoracsur.2024.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。